达他林的使用和割抵抗性前列腺癌的瘤治疗结果
A I Peltomaa1,2, K Talala3, K Taari4
1Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Teiskontie 35, 33521, Tampere, Finland. antti.peltomaa@tuni.fi.
Scientific reports
|November 2, 2023
概括
达丁类药物的使用可能会降低患有抵抗割的前列腺癌 (CRPC) 的风险. 然而,一旦CRPC治疗开始,他类药物并没有改善结果,这表明在前列腺癌早期阶段有好处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 前列腺癌 (PCa) 治疗通常涉及雄激素剥夺疗法 (ADT).
- 抗割前列腺癌 (CRPC) 是一个晚期的,更具侵略性的阶段.
- 现在正在研究他类药物对前列腺癌进展和治疗的作用.
研究的目的:
- 评估他类药物使用与在ADT治疗患者中启动CRPC治疗的风险之间的关联.
- 评估他类药物使用对CRPC治疗疗法的疗效的影响.
- 为了确定他类药物是否会影响由于CRPC的无效性而中止治疗.
主要方法:
- 来自芬兰前列腺癌查随机研究 (FinRSPC) 的1169名男性队伍的分析.
- 患者在1996年至2017年期间启动了ADT.
- 在他类药物使用者和非使用者之间,CRPC启动风险和治疗结果的比较.
主要成果:
- 斯坦丁使用与开始CRPC治疗的风险降低有关 (HR 0.68).
- 对于他类药物使用者 (7.5年),CRPC的中位时间比非使用者 (5.7年) 长.
- 斯坦丁的使用并没有改变CRPC治疗因无效性而中止的风险.
结论:
- 立方体使用可能与延迟发病的抵抗割的前列腺癌有关.
- 类药物似乎不会改变已建立的CRPC治疗方法 (taxanes,ARSI) 的疗效.
- 研究结果表明,在前列腺癌的荷尔蒙敏感阶段,他类药物可能有好处,但在CRPC中没有.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K